BlackRock, Inc. 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-27 4:25 pm Purchase | 2026-06-30 | 13G | ARS PHARMACEUTICALS, INC SPRY | BlackRock Inc. BLK | 5,218,264 5.300% | 271,852 (+5.50%) | Filing |
| 2026-04-27 4:12 pm Sale | 2026-03-31 | 13G | ARS PHARMACEUTICALS, INC SPRY | BlackRock Inc. BLK | 4,946,412 4.980% | -66,588 (-1.33%) | Filing |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | ARS PHARMACEUTICALS, INC SPRY | BlackRock Inc. BLK | 5,013,000 5.100% | 5,013,000 (New Position) | Filing |